Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone in type 2 diabetic nephropathy with overt proteinuria
ChiCTR-TNC-10001154Phase 4Completed
- Sponsor
- Qingdao Municipal Hospital
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of spironolactone in diabetic glomerulosclerosis and type 2 diabetes mellitus (T2DM), sponsored by Qingdao Municipal Hospital. Primary endpoints: circulating type IV collagen, aldosterone and 2 more. Started Jan 2010; status: completed.
02
Drugs
spironolactone
03
Conditions
diabetic glomerulosclerosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TNC-10001154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-10001154.